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Anti-IgG autoantibodies directed against the constant region of the IgG molecule 
are  regularly  found  in  a  number  of diseases.  They  are  often  collectively  called 
rheumatoid factors (RF), 1 although their specificities tend to vary from one disease to 
another.  In rheumatoid arthritis,  for example, reactions have been described with a 
subclass-specific antigen called Ga, with many different Gm allotypic markers, and 
with  heterologous  IgG  (1-3).  On  the  contrary,  in  subacute  bacterial  endocarditis, 
anti-IgG autoantibodies are generally useless  for Gm-typing and show little,  if any, 
reaction  with  heteroiogous  IgG  (3). Whether  these  differences  correspond  to  the 
existence of specific stimuli  that  vary from one disease  to another, or whether they 
reflect intrinsic differences in the anti-IgG repertoire of individuals that are prone to 
develop these diseases is not known. 
Similar specificity differences have been observed for the anti-IgG autoantibodies 
spontaneously produced by certain  mouse strains  in  some colonies. These  anti-IgG 
autoantibodies exhibit  a  restricted  specificity for certain  mouse IgG subclasses  that 
varies from one strain to another;  most bind preferentially to IgG2a but some react 
better with IgG1 (4, 5). In this case, genetic studies have demonstrated (6) an allotype- 
linked  control of the levels  of these  autoantibodies  and  suggested a  similar  type of 
control for their specificities. Yet, like for human RF, the actual origin of the specificity 
differences between mouse anti-IgG autoantibodies remains unknown. In this context, 
it was of interest to find out whether the narrow specificity of some mouse RF is due 
either to the existence of highly selective stimuli that trigger only a small number of 
RF-secreting clones, or to a relative oligoclonality of the mouse RF repertoire. 
As a first step in this investigation, we have attempted to identify at the clonal level 
the RF specificities encoded in the repertoire of a  strain,  namely the  129/Sv, that's 
characterized by a  spontaneous production of IgG2a-specific RF. We have therefore 
analyzed the specificities of the monoclonal RF secreted by hybridomas derived from 
129/Sv  spleen  cells  that  had  been  polyclonally activated  in  vivo with  a  bacterial 
lipopolysaccharide (LPS). The results demonstrate that RF spontaneously produced 
by  the  129/Sv  mice  represents  only  a  minor  component  of a  highly  diversified 
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repertoire. They also show that a  large proportion of the B lymphocytes activated by 
LPS are committed to the secretion of anti-IgG autoantibodies. 
Materials and Methods 
Mice.  129/Sv mice were maintained in the specific pathogen-free colony of our institute by 
Dr. Guy Warnier. These mice were originally derived from breeders obtained from Dr. J.-L. 
Gu~net, Institut Pasteur, Paris, France. 
Polyclonal Stimulation with LPS.  Mice were inoculated intraperitoneally  with 50 ~g LPS from 
Escheriehia coli 055:B5  (Difco Laboratories, Detroit, Mich.) in 200 #1 sterile saline. Their spleen 
cells were used for hybridization 3-4 d later. 
Cell Fusion and Culture.  Hybrid clones were obtained by fusing LPS-activated spleen cells 
and SP2/0-Ag-14 myeloma cells (7) at a  10:1 ratio with 30% polyethylene glycol,  1,000 mol wt 
(BDH,  Poole,  England),  essentially as  described  by  Clafiin  and  Williams  (8). The  only 
modification was the use of a th~mocyte-conditioned medium to clone the cells. This medium 
was obtained by culturing 2 x  10  thymocytes from 4-wk-old  129/Sv mice in 1 ml of Dulbecco's 
modified Eagle's medium supplemented with 30% fetal bovine serum, L-glutamine (1.5 X 10  -3 
8  3  M), L-asparagine (0.24 ×  10-  M), L-arginine (0.55 X  10-  M), and 2-mercaptoethanol (5 × 
10  -5  M).  After  24  h,  the  cells  were  centrifuged and  the  medium kept  frozen  at  -30°C. 
Thymocyte-conditioned  medium was also used to support the growth of selected clones in mass 
cultures. The myeloma cells were grown in Dulbecco's modified Eagle's medium supplemented 
with 10% fetal bovine serum. 
Radioimmunoassays.  Polypropylene wells (Removawell; Dynatech, Kloten, Switzerland) were 
coated by overnight incubation at room temperature with 25/.tl of a  10 ~tg/ml protein solution 
in diluted glycine-buffered saline (0.02 M  glycine, 0.03  M  NaCI, pH 9.2).  After washing in 
saline containing 0.1  ml Tween 20  (Technicon Chemicals, Orcq,  Belgium) per liter (NaCI- 
Tween), they were incubated overnight at  37°C either with control culture medium or with 
medium from hybrid cell cultures. After further washing with NaCI-Tween, they were incubated 
at  37°C for 4 h  with ~2SI-labeled affinity-purified goat antibodies specific  for mouse IgM or 
IgA.  Bound radioactivity was counted after a  last  series of four washes  in NaC1-Tween. The 
specifically bound radioactivity was calculated by subtracting the counts per minute associated 
with wells incubated with control medium. As the data obtained in direct binding assays were 
of the all or none type, they were expressed as specifically bound radioactivity. For competition 
experiments, we calculated the exact amount of RF bound per well by reference to a standard 
curve constructed with known quantities of 125I-labeled IgM  (MOPC  104E) bound to wells 
coated with anti-mouse IgM antibodies. 
IgG Preparations 
Mouse IgG1.  The following three preparations were used: MOPC 3 lc, a BALB/c myeloma 
protein, HI08B7, a  129/Sv hybridoma obtained from unstimulated 129/Sv spleen cells, and 
polyclonal IgG1  isolated from the serum of C57B1/6  mice. All preparations were purified by 
elution from protein A-Sepharose with 0.1  M  citrate buffer at pH 6.0. As checked by double 
immunodiffusion  in agarose gel, these three preparations were free of other subclasses. 
Mouse IgG2a.  To test  the potential allotypic specificity of anti-IgG hybridomas, we used 
two IgG2a  ~ molecules and one IgG2a  b preparation. These were,  respectively, MOPCI73, a 
BALB/c IgG2a myeloma, H  1103G4, a  129/Sv hybridoma derived from LPS-activated 129/Sv 
spleen cells,  and polyclonal IgG2a isolated from the serum of SjL/j mice, which have the 
IgG2a  h allotype. These preparations were obtained by elution from protein A-Sepharose with 
a  0.1  M  citrate buffer, pH  5.0.  Whereas no contamination with other subclasses could be 
detected by double immunodiffusion in the monoclonal IgG2a proteins, IgG1  and some IgG3 
were found in the polyclonal IgG2a of SJL mice. The contaminating IgG1  was  removed by 
passage  through  a  rabbit  anti-mouse IgG1-Sepharose column. No  attempts  were  made  to 
remove the traces of IgG3 detected in this preparation. 
Mouse IgG2b.  We used H308A8, an IgG2b monoclonal protein secreted by a hybridoma 
derived  from  LPS-activated  129/Sv  spleen cells.  This  protein  was  found  to  be  devoid  of 
contaminating subclasses after elution from protein A-Sepharose at pH 3.0. VAN  SNICK  AND COULIE  221 
Mouse IgG3.  We used the BALB/c myeloma protein, FLOPC21, which was isolated by 
elution at  pH 5.0  from protein A-Sepharose and subsequent  passage through a  rabbit  anti- 
IgG2a-Sepharose column.  All  BALB/c  myeloma  cells  used  in  this  study  were  generously 
provided by Dr. M. Potter (National Institutes of Health, Bethesda, Md.). 
RAT IgG SUBCLASSES.  Purified rat IgG subclasses  were kindly provided by Dr. Hervfi Bazin 
(Experimental Immunology Unit, Universit~ Catholique de Louvain, Brussels,  Belgium). 
OrdER IgG PRWPARATIONS.  Bovine IgG1 and IgG2 and chicken immunoglobulins were gifts 
of Dr. J. P. Vaerman, and human IgG subclasses  were provided by Dr. D. Delacroix, both from 
this laboratory. Goat IgG1 and IgG2 were isolated as described in Delacroix and Vaerman (9) 
with a slight modification. In brief, goat IgG purified by chromatography on DEAE-cellulose 
was passed through a  protein A-Sepharose column in a 0.1  M  phosphate buffer, pH 8. Pure 
IgG 1 was recovered in the flowthrough. After washing with 0.1 M phosphate, pH 6.5, the IgG2 
was eluted  in 0.1  M  citrate buffer, pH 5.9.  Purity was checked by double immunodiffusion 
with  subclass-specific  rabbit  antisera.  Rabbit  IgG  was  isolated  by  precipitation  with  50% 
saturated ammonium sulfate followed by chromatography on DEAE-cellulose. 
Heat Aggregation of Immunoglobulins.  The various IgG subclasses  were dissolved in phosphate- 
buffered saline  (pH  7.5) at  a  concentration of 5  mg/ml.  They were then  heated  until  they 
became opalescent. The time and temperature needed for aggregation to occur varied widely 
from one subclass to another, ranging from 10 min at 63°C for mouse IgG3 to ~ 1 h at 75°C for 
mouse IgG1. 
Fab and Fc Fragments.  HI08B7  (100  mg)  was  digested  with  1 nag  papain  (Boehringer, 
Mannheim, West Germany) at 37°C for 24 h in a 0.1  M  phosphate buffer, pH 8, containing 
0.001  M  EDTA and 0.02  M cysteine. The reaction was stopped by addition of a slight excess 
of iodoacetamide. The mixture was then submitted to gel filtration on AcA 44 Ultrogel (LKB, 
Bromma, Sweden). This produced two peaks, the first containing pure Fc fragments, and the 
second consisting of Fab slightly contaminated with  Fc fragments. The Fab  fragments were 
further purified by passage through a protein A column that selectively retained the contami- 
nating Fc fragments. 
Latex Agglutination Tests.  These were carried out with the Technicon PACIA system (Tech- 
nicon Instruments Corp., International Division, Geneva, Switzerland) as described previously 
(6). Polystyrene particles (0.8 ~m Diam) were a girl from Rh~ne-Poulenc (Courbevoie, France). 
The particles were coated by incubating 250/~g protein and 50/tl of a  10% particle suspension 
in a  total  volume of 500/~1 of 0.02  M  glycine and 0.03  M  NaCI pH 9.2  for 45 min at  room 
temperature. After one washing with the same buffer, the particles were resuspended in 1 ml of 
0.1 M  glycine and 0.15 M  NaCI pH 9.2 containing 1% bovine serum albumin. Before use, this 
suspension was further diluted  10 times in the same buffer. 
Results 
Hybridomas Secreting Anti-IgG  Autoantibodies.  Four  hybridizations  were  carried  out 
with  spleen  cells  from 20-wk-old  129/Sv  mice that  had  received  an  intraperitoneal 
injection of 50 #g LPS 3-4 d before. For each hybridization, the spleen cells collected 
from three  mice were pooled.  After hybridization,  the cells were cloned by limiting 
dilution  in 3,000 microtiter wells.  1 wk later, clones of hybrid cells were observed in 
500-1,000 wells. When the clones covered at least 20% of the surface of the well, they 
were tested for the production of IgM anti-IgG autoantibody. The four hybridizations 
yielded  8,  5,  32,  an  23  stable  hybrid  cell  lines,  respectively,  all  secreting  anti-IgG 
autoantibodies.  Typical screening data are shown in Table I. 
The  frequency  of  anti-IgG  secreting  clones  was  ~3%  of  the  total  number  of 
hybridomas.  From  the  Poisson  distribution,  it  follows that  only ~1.5%  of the  wells 
with  anti-IgG activity contained more than one anti-IgG secreting clone. Therefore, 
anti-IgG secreting clones were expanded without further subcloning and their culture 
medium used directly for the specificity assays. 
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TABLE  I 
Detection of Hybridomas Secreting IgM Anti-Mouse IgG Autoantibodies 
Hybridomas 
IgM bound to wells coated with 
BSA*  129/Sv IgG 
1413 A3  48 ±  29  520 ±  24 
1415 C7  30 ±  31  2,500 ±  13 
1415 D9  43 ±  39  2,280 ±  12 
1303 A6  7 ±  12  1,750 ±  25 
The binding of IgM antibodies to polypropylene wells coated with 10/.tg/ml 
BSA  or  129/Sv  IgG  was  determined  as  described  under  Materials  and 
Methods.  The  values represent  specifically bound counts per  minute and 
correspond to the mean of three determinations ±  1 SD. The nonspecifically 
bound  radioactivity  was 200 and  750 cpm for  BSA and IgG-coated wells, 
respectively. 
* Bovine serum albumin. 
TABLE  II 
Binding of Monoclonal 129/Sv Anti-IgG Autoantibodies to Mouse IgG Subclasses* 
Hybridomas 
Antibody bound to wells coated with 
IgG 1  IgG2a  IgG2b  IgG3 
1301 G3  3,055 ±  244  0  0  0 
1305 B4  3,627 +  1,068  94 ±  20  0  0 
1307 A6  2,773 +  46  0  0  0 
1310 BI  3,040 ±  178  0  0  0 
1309 GI  1,925  ±  114  0  0  0 
1312 A3  1,496  ±  540  0  0  0 
1408 GI1  2,659 ±  453  0  0  0 
1402 H9  1,179  ±  303  0  0  0 
1408 F8  1,856  ±  1,000  0  0  0 
307 All  5,870 ±  621  4,439 ±  526  0  0 
1302 G1  3,36l  ±  140  1,549  ±  819  0  0 
1415 C7  3,877 ±  671  1,157  ±  263  0  0 
1415  D9  4,716 ±  756  1,531  ±  188  0  0 
1303 A6  2,733 ±  891  891  ±  384  0  589 ± 
1305 A9  0  2,606 ±  430  0  0 
102 C6  0  2,638 ±  81  1,036 +  30  0 
123 
* Polypropylene wells were coated with  10 #g/ml of the following IgG preparations:  H 108 
B7, a  129/Sv monoclonal IgG1; MOPC  173, a  BALB/c IgG2a myeloma protein;  H308A8, 
a  129/Sv  monoclonal  IgG2b;  and  FLOPC  21,  a  BALB/c  IgG3  myeloma protein.  The 
values represent specifically bound counts per minute, obtained after substraction of the 
nonspecific binding to wells incubated with control medium. The latter amounted to ~600 
cpm in all cases. Each value represents the mean of three determinations +  1 SD. Binding 
of monoclonal antibodies  to  these wells was determined  by  ~2%labeled  affinity-purified 
goat anti-mouse lgM antibodies in all cases except  for  102 C6, which was revealed with 
goat anti-mouse IgA antibodies. 
with  LPS  yielded  160  hybrid  clones,  only  1  of which  secreted  an  anti-IgG  autoanti- 
body.  This  autoantibody,  of the  IgA  class, was  included  in  the subsequent  specificity 
studies. 
Specificity of Monoclonal Anti-IgG Autoantibodies  for Mouse IgG Subclasses.  The  specific- 
ities  of 68  monoclonal  anti-IgG  autoantibodies  were  first  tested  by  measuring  their 
ability  to  bind  to  wells  coated  with  various  mouse  IgG  subclasses.  The  majority  of VAN SNICK AND COULIE  223 
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F[~;.  1.  Reaction  of monoclonal anti-IgG autoantibodies with  heat-aggregated  mouse IgG sub- 
classes. The binding of monoclonal  antibodies  1312A3 and  1309G1 to  wells coated  with IgG1 
(H 108B7) was measured in the presence of various concentrations of heat-aggregated IgG1 (H 108B7, 
O), IgG2a (MOPC  173, A), IgG2b (H308A8, V), and IgG3 (FLOPC21, i). A similar experiment 
was carried out with antibody 1305A9 in wells  coated with IgG2a (MOPC 173). 
TABLE III 
Allotypic Specificity of Monoclonal 129/Sv Anti-lgG Autoantibodies 
Hybridomas 
Antibody* bound to wells  coated with 
IgG1"  IgGl  b  IgG2a  a 
H108B7  Polyclonal:]:  MOPC173  1103G4 
IgG2a  b 
Polyclonal§ 
Anti-IgGl clones 
1301 G3 
1307 A6 
1408 F8 
1408 G4 
Anti-IgG2a clones 
1305 A9 
102 C6 
6,518  6,536 
5,209  5,572 
3,787  2,702 
5,239  4,069 
1,100  1,390  0 
1,288  2,077  1,386 
* Measured as in Table II. 
Isolated from the serum of C57B1/6 mice. 
§ Isolated from the serum of SJL/J mice. 
these clones (58 of 68)  reacted exclusively with  IgG1. This preferential binding was 
observed  with  two  different  IgG1  preparations:  MOPC  31C,  a  BALB/c  myeloma 
protein, and  H108B7,  a  129/Sv  hybridoma of unknown  specificity. A  second group 
of eight clones reacted mainly with  IgG1  but cross-reacted significantly with IgG2a. 
One  monoclonal  antibody  bound  to  IgG1,  IgG2a,  and  IgG3,  and  one  (1305A9) 
reacted  only  with  IgG2a.  The  monoclonal  anti-IgG  autoantibody  derived  from 
unstimulated  129/Sv  spleen cells  (102C6)  bound  preferentially to  IgG2a but  cross- 
reacted with IgG2b (Table II). 
Similar specificity patterns were obtained in agglutination assays using polystyrene 
particles coated with  129/Sv IgG1 and IgG2a. These data, which were confirmed by 224  MONOCLONAL  MOUSE  ANTI-IgG  AUTOANTIBODIES 
TAm.r  IV 
Relative Binding of Monoclonal Anti-lgG Autoantibodies to Heterologous IgG Subclasses* 
Specifichy for mouse 
1~,<; 
Rat  Cow  Goat  Rabbil  Human 
lgG1  lgG2a  tgG2b  lg,G2c  Ig(;l  lg'G2  I+,,GI  lgG2  I+,,G  IgGI  IRG2  IgG3  lg(;4 
Anti-Ig'G I 
1311 l G3  2.98  0  0.06  1.98  0  3.03  0  1 69  2.579  0  0+02  0  0.10 
1304H2  2.63  0.02  0.09  1.98  0  3,03  (1  1 39  2. I 8  17  0  0  (1(73 
1312A3  2.09  0  0.10  1.82  0  2.17  0  121  2.18  0.02  001  (7  0 
1408GI i  212  (/.05  (/.11/  1.46  002  314  004  151  1.64  0.02  01)[  0  (J 
1312B|2  I.94  (1.02  ~  t.96  0  1.9{/  0.01  I 06  2.06  0.(H  0.0l  9  (J 
1314CI0  2.39  0  ]0.841  1.86  0.01  3.42  010  132  2.3"1  0.1/5  0  003  0 
[-~  0.07  146  0  3+79  0,02  1.75  2.99  0.02  002  0.113  t)  1415BI2  2.70 
1408F8  4.04  ~  5.65  0.10  7.54  (723  2.96  4.02  0.11  o.113  (708  0.02 
1307A6  1.67  1.17  0.17  [.06  [~]  2.34  ~  083  136  0.02  0112  0.01  0 
(I.04  4.41  ~  5.07  1.41  ,1525  3.32  219  1.14 I  1309GI  10.53  o+69  0.27  529 
Anti- lgGI and 
lgG2a) 
307AI t  3.75  0.01  ~  4.13  0  4.43  0  2 37  3.97  0  0  0  0 
302(;I  2.56  0  ~  2.32  0  2.65  13  1.35  2.56  0  0  0  0.(13 
1415C7  2.31  004  2+(19  (3  2.52  0.02  I 22  2,(19  0.01  001  0.02  0 
1415I)9  2.48  0  208  0  2.5(1  (1  I 32  2.36  (I  (J  (3  (3(/2 
And-lgG2a 
t 305A9  It  1)  {J  0  0  (I  --  11  --$  -- 
Anti-(lgG2a and 
l+.,,(;2b) 
102C6  0  0  0  0  0  0  --  --  0  --~:  -- 
* Wells were coated with  10 ~g/ml of the following IgG preparations: IR27, a monoclonal rat IgGl; 
IR1025, a monoclonal rat IgG2a; IR863, a monoclonal rat IgG2B; IR304, a monoclonal rat IgG2c; 
polyclonal cow IgGl and IgG2; polyclonal goat IgG1 and IgG2; polyclonal rabbit IgG; To., a monoclonal 
human IgG1; Me., a monoclonal human IgG2; Ba., a monoclonal human IgG3; and Ro., a monoclonal 
human IgG4. The relative binding to heterologous IgG was expressed as the ratio between counts per 
minute specifically bound to heterologous IgG and counts per minute specifically bound to the autologous 
IgG subclass. Ratios <0.01  were listed as 0. Cross-reactions critical for the definition of individual anti- 
IgG specificities were boxed. 
:~ 1305A9 and 102C6 have been tested separately on wells coated with a pool of human IgG. No binding 
was observed. 
competition experiments with heat-aggregated  IgG subclasses (Fig.  1), demonstrated 
the existence of five different clonotypes of anti-IgG autoantibodies. 
Allotypic Specificity of Monoclonal Anti-IgG Autoantibodies.  As reported previously, the 
anti-IgG2a autoantibodies spontaneously produced by  129/Sv mice, which carry the 
Igh-C" allele, fail to react with IgG2a of the b  allotype, while the anti-IgG1  detected 
in  the  serum  of certain  C57B1/6  mice  which  carry  the  Igh-C b  allele  bind  nearly 
equally well to IgG1  of 129/Sv or C57B1/6 origin (5). It was interesting, therefore, to 
find out whether the  129/Sv monoclonal anti-IgG autoantibodies would display any 
allotypic specificity. 
Accordingly, we tested the binding of the  129/Sv monoclonal anti-IgG1  autoanti- 
bodies to wells coated with polyclonal IgG1  isolated from C57B1/6 serum, and found 
it similar to that observed when the wells were coated with H 108B7, the monoclonal 
129/Sv  IgG1  used  in  the previous experiments.  In contrast,  monoclonal anti-IgG2a VAN SNICK AND COULIE  225 
autoantibody  1305A9  exhibited  a  strong  allotypic  specificity,  no  reaction  being 
detected with IgG2a isolated from the serum of Igh-C  b mice. This allotypic specificity 
was not observed for 102C6, the antibody reactive with IgG2a and IgG2b (Table III). 
Binding of Monoclonal Anti-IgG Autoantibodies to Heterologous IgG Subclasses.  Binding to 
wells  coated  with  14  different  heterologous  IgG  preparations  was  measured  after 
appropriate  dilution  of the  culture  medium so as  to  obtain  80%  of the  maximum 
binding to the autologous IgG. Representative results are shown in Table IV. The 34 
anti-IgG1  monoclonal autoantibodies  tested  in  these experiments all reacted  better 
with rat  IgG1 and IgG2c, bovine and goat IgG2, and rabbit IgG, than with  mouse 
IgG1. Four major clonotypes could  be distinguished  by the  presence or absence of 
additional cross-reactions. Thus, clonotype I  (14 antibodies)  cross-reacted only with 
the IgG mentioned above, whereas clonotype II (11  antibodies)  reacted in addition 
with  rat  IgG2b, clonotype II! (5  antibodies)  with  rat  IgG2a, and  clonotype  IV  (4 
antibodies) with rat IgG2a and IgG2b. Three additional specificities were determined 
by the binding of antibody  1307A6 to bovine and goat IgG1, of antibody  1309G1  to 
goat IgG1 and human IgG subclasses, and of antibody  1405A9 to chicken immuno- 
globulins  (data  not  shown).  Altogether,  seven  different  anti-IgG1  specificities were 
identified by these cross-reactions. 
The monoclonal antibodies  that reacted with mouse IgG1 and IgG2a all had the 
same cross-reaction pattern with heterologous IgG: in addition  to the characteristic 
cross-reactions of all anti-IgG1 autoantibodies with rat IgG1 and IgG2c, bovine and 
goat  IgG2,  and  rabbit  IgG,  they  all  displayed  a  strong  binding  to  rat  IgG2b.  In 
contrast to the extensive cross-reactions of anti-IgG1 antibodies, no cross-reaction was 
detected  between  the  two  anti-IgG2a  autoantibodies  (102C6  and  1305A9)  and 
heterologous IgG subclasses. 
To check some of the data obtained in direct binding assays, we tested the ability 
of various  heat-aggregated  IgG preparations  to  inhibit  the  binding  of monoclonal 
~100 
0 
re" 
t-- 
Z  80 
0 
c~ 
LL 
0 
121 
0  ~0 
m 
I-- 
Z 
D 
Z 
"-1 
0  m 
•  • 
20 
130901  1305A9 
I  !  i  i 
o  Q's  ~6  s  ,'~  s'oo  ~s  116  ~  I~  ~oo  &  119  ~  i's  1o 
CONCENTRATION  OF  COMPETING PROTEIN (~uglml} 
Fzo.  2.  Reaction of monoclonal anti-lgG autoantibodies with bovine and human  IgG aggregated 
by heating. The binding of monoclonal antibodies 1312A3 and 1309131 to wells coated with IgG1 
(H 108B7) was measured in the presence of various concentrations of heat-aggregated bovine IgG2 
(Q) and human IgG (O). A similar experiment was carried out with antibody 1305A9 in wells 
coated with IgG2a (MOPC  173). 226  MONOCLONAL MOUSE  ANTI-IgG AUTOANTIBODIES 
TABLE V 
Agglutinating Activity  of 129/Sv Monoclonal Anti-]gG Autoantibodies toward Polystyrene 
Particles Coated with Autologous and Heterologous IgG Subclasses 
Agglutination* of particles coated with 
Hybridomas  Mouse  Mouse 
Cow IgG1][ Cow IgG2][ Goat IgGl]l  Man IgGI]  IgGl:[:  IgG2a§ 
1301 G3  >80  0  0  >80  0  0 
1304H2  >80  0  0  >80  0  0 
1312A3  >80  0  0  >80  0  0 
1408G 11  70  0  0  >80  0  0 
1307A6  >80  0  >80  >80  >80  0 
1309(31  >80  0  0  >80  0  75 
307A 11  >80  >80  0  >80  0  0 
1415C 7  >80  >80  0  >80  0  0 
141509  >80  >80  0  >80  0  0 
1305A9  0  >80  0  14  0  0 
102C6  0  78  0  12  0  0 
* Measured by the Technicon PACIA system (6) and expressed in percent of agglutinated 
particles. 
:~ H 108B7, monoelonal IgG1 of 129/Sv origin. 
§ H1103G4, monoelonal IgG2a of 129/Sv origin. 
[I Polyclonal. 
antibodies to wells coated with their autologous target. These competition experiments 
confirmed the cross-reactions observed in direct binding assays. Three representative 
experiments are shown in Fig. 2. 
The results obtained by the radioimmunoassays were checked further by measuring 
the  agglutinating  activities  of selected  anti-IgG  hybridomas  toward  latex  particles 
coated with various IgG preparations.  The results of these agglutination experiments 
were clear-cut and confirmed the cross-reactions observed in the radioimmunoassays, 
except that of antibody  1309GI with goat IgGl  (Table V). 
Reaction  of  Monoclonal  Anti-IgG1  Autoantibodies  with  Mouse IgG1  Fab  and  Fc 
Fragments.  To localize the antigenic sites recognized by the LPS-induced monoclonal 
anti-IgG1 autoantibodies, we measured their binding to wells coated with Fab and Fc 
fragments obtained by papain  digestion of a  monoclonal IgG1, H108B7.  Of 48 anti- 
IgG1  monoclonal  antibodies  tested,  all  but  1 failed  to  react  with  either  fragment, 
suggesting that they are directed against  antigenic determinants  located in the hinge 
region of the IgG1 molecule. The exception was monoclonal  1405E9,  which showed 
a  significant  reaction  with  the  IgG1  Fc  fragments.  Incidentally,  this  was  the  only 
monoclonal that bound to chicken IgG. 
Discussion 
To analyze the mouse repertoire of anti-IgG autoantibodies,  we have attempted  to 
derive  hybridomas with  anti-IgG activity from the spleen  cells of 20-wk-old  129/Sv 
mice that  had been inoculated  3 d  before with  LPS to polyclonally activate their B 
lymphocytes.  We  have  obtained  68  hybridomas  that  produce  monoclonal  IgM 
antibodies capable of binding to wells coated with autologous IgG. VAN SNICK AND COULIE  227 
This represents -3% of the total number of hybrids generated in four hybridizations, 
a frequency not wholly unexpected in view of the observation by Dresser  (10) that in 
old CBA  mice  most  of the plaque-forming  cells  that secrete  IgM  after  stimulation 
with  endotoxin have  RF  activity.  Also,  a  high proportion  (4%)  of the monoclonal 
IgM occurring in WaldenstriJm's macroglobulinemia have been found to exhibit RF 
activity  (11,  12). This latter finding was taken to suggest  that autoantibody-synthe- 
sizing  clones  might  be  more  likely  to  undergo  neoplastic  transformation.  Such  an 
explanation is obviously irrelevant with respect to the frequency of anti-IgG secreting 
hybridomas  obtained  after  in  vivo  stimulation  with  LPS.  Provided  LPS-activated 
spleen cells accurately reflect the total B lymphocyte population, one has therefore to 
admit that -1  of 30 B lymphocytes is committed to the production of autoantibodies 
directed against the constant part of the IgG molecule. This would support previous 
suggestions  (10,  13)  that  RF  might  play  a  physiological  role  in  normal  immune 
responses.  It will therefore be of interest to find out whether hybridomas with anti- 
IgG  activity  occur  at  the same  frequency  in  mice  that,  unlike  the  129/Sv,  do  not 
spontaneously produce large amounts of anti-IgG autoantibodies. 
Besides  their frequency,  the anti-IgG clones obtained  here were  characterized  by 
their narrow specificity for individual mouse IgG subclasses. The majority (59 of 68) 
TABLE  VI 
Reactivity Patterns of Monoclonal Anti-lgG Autoantibodies of 129/ Sv Mice 
And-lgG  clonotypes  (prototype clone) 
IgG  prepara- 
tions  I  II  Ill  IV  V  VI  VII  ',,'[11  1X  X  XI 
(1301G3)  (1314C10)  (1415B12)  (1408F8)  (1307A6)  (1309(31)  (1405A9)  (1415C7)  (1303A6)  (1305A9)  (I02C6) 
Mouse 
lgGl  +  +  +  +  +  +  +  +  + 
lgG2a  ....  +  + 
I  gGZb  ....... 
IRG3  ......  + 
lgGl  Fc  .....  +  -  - 
Rat 
lgOl  +  +  +  +  +  +  +  +  + 
lgG2a  -  +  +  +  +  -  - 
IgG2b  -  +  -  +  -  -  -  + 
lgG2c  +  +  +  +  +  +  +  +  + 
Cow 
IgGl  -  -  -  +  -  -  - 
IgC:2  +  +  +  +  +  +  +  +  + 
Goat 
IgGl  -  -  -  +  (+)~:  -  -  - 
lgG2  +  +  +  +  +  +  +  +  + 
Rabbit 
IgG  +  +  +  +  +  +  +  +  + 
Human 
IgGI  ....  +  -  -  - 
IR;G2  .....  +  -  -  - 
IR;03  .....  +  -  -  - 
lgG4  .....  +  -  --  -- 
Chicken 
IgG  ....  +  -  - 
+  + 
--  + 
NT"  NT 
* Not  tested. 
~c Positive in radioimmunoa.~ay only. 228  MONOCLONAL MOUSE ANTI-IgG AUTOANTIBODIES 
were indeed  specific for a  single mouse IgG subclass.  Most  reacted exclusively with 
IgG1, only two were specific for IgG2a, and none was found to react specifically with 
either IgG2b or IgG3. This predominance of anti-IgG1 clones was totally unexpected 
in view of the spontaneous production of anti-IgG2a by the 129/Sv mice used in these 
experiments. One could argue that the low anti-IgG2a frequency was precisely due to 
the continuous removal of anti-IgG2a precursors from the pool of cells responsive to 
LPS. This explanation, however, seems unlikely, as we observed the same anti-IgG1 
predominance  in  RF-negative  129/Sv  mice  (data  not  shown).  The  significance  of 
these anti-IgG autoantibodies remains, at present, totally mysterious, and any specu- 
lation about their potential role has to await more information on their capacity to be 
activated in vivo. It is however intriguing that all the anti-IgG autoantibodies detected 
in our experiments were primarily directed  against  IgG1  or IgG2a, which  together 
represent ~80% of the mouse immunoglobulins. 
The narrow specificity of these anti-IgG autoantibodies for individual  mouse IgG 
subclasses contrasted sharply with the extensive cross-reactions of all anti-IgG1 clones 
with  rat  IgG1  and  IgG2c,  bovine  and  goat  IgG2,  and  rabbit  IgG;  this  finding  is 
reminiscent of some human RF that react better with rabbit than with human IgG 
(14).  The antigenic similarity of these IgG subclasses and mouse IgG1 had not been 
recognized with conventional xenoantisera. A likely explanation for this observation 
is that these reactions involve highly conserved structures that are also present on the 
IgG of the immunized animal. Monoclonal anti-IgG autoantibodies might thus be of 
interest in the study of phylogenic relationships between immunoglobulins. 
Altogether,  analyses  of  the  specificities  of  the  monoclonal  RF  obtained  after 
polyclonal activation of 129/Sv B lymphocytes identified  11  different RF clonotypes 
(Table VI). This figure is most certainly an underestimation of the actual number of 
RF specificites encoded in the repertoire of these mice because 6 of 11 clonotypes were 
represented by single antibodies.  In view of this  great  diversity, it  is not  surprising 
that the RF activity detected  in the serum of animals injected with LPS shows little 
specificity for any particular IgG subclass (15).  Our data strongly suggest that this is 
due  to  the  simultaneous  activation  of a  large  number of different  anti-IgG clones, 
rather than to an intrinsic lack of specificity of LPS-induced RF. 
The RF spontaneously produced by 129/Sv mice, which carry the Igh-C  aa genotype, 
binds  preferentially  to  mouse  IgG2a but  fails  to  react  with  either  IgG2a of the  b 
allotype or heterologous IgG subclasses (4). Only  1 of the  11  RF clonotypes identified 
in  the present study  (1305A9)  displays such a  specificity. This clearly demonstrates 
that in vivo only a  minor part of the RF repertoire is activated in these mice. What 
actually determines the in vivo specificity of RF remains unknown. We have previously 
shown  (6)  that  the  subclass  specificity of the  RF  found  in  the  progeny of various 
(129/Sv  ×  C57BI/6)  crosses varies according  to the  Igh-C genotype of these  mice, 
Igh-C  aa  mice  producing  mainly  anti-IgG2a,  and  Igh-C  bb  mice  mainly  anti-IgG1. 
However,  it  was  not  clear  whether  this  regulation  was  controlled  by the  constant 
region of the Ig heavy chain  (Igh-C)  locus itself, or by a closely linked locus such as 
the variable region of the Igh (Igh-V) locus. The present observation that mice, which 
actively produce anti-IgG2a, have many silent anti-IgG1 clones indicates that the in 
vivo specificity of RF does not just reflect the repertoire of RF-encoding Igh-V genes 
associated with a particular Igh-C allele. 
The production of autoantibody-secreting hybridomas, as illustrated  for RF in the VAN SNICK AND COULIE  229 
present work, might be useful to investigate the origin of autoimmune reactions in 
general. It is indeed theoretically possible to unmask the whole autoimmune repertoire 
by deriving hybridomas from LPS-activated spleen cells.  Comparison  of the  auto- 
antibodies actually produced in certain diseases  to those potentially available from 
the repertoire might help to determine whether particular autoimmune reactions are 
induced by specific or polyclonal stimuli. 
Summary 
In some colonies, 129/Sv mice produce, upon aging, a rheumatoid factor (RF) that 
is specific for mouse IgG2a but fails to react with IgG2a of the b  allotype. It is not 
known whether this narrow specificity is due to the absence of other RF specificities 
in the repertoire of these mice or to the selective activation of the production of anti- 
IgG2a autoantibodies by a specific stimulus. To analyze the RF repertoire of 129/Sv 
mice, we have derived hybridomas from their spleen cells 3 d after an intraperitoneal 
injection of lipopolysaccharide. We have obtained 68 hybridomas secreting a mono- 
clonal IgM with RF activity. This represents -3% of the total number of hybridomas 
generated in four hybridizations. In addition, one monoclonal IgA RF was derived 
from unstimulated  129/Sv spleen cells. 
The specificities of these monoclonal RF were examined by testing their ability to 
bind to a  panel of homologous and heterologous IgG preparations. The majority of 
the IgM RF reacted exclusively with a single mouse IgG subclass:  58 with IgG1, and 
1 with IgG2a.  Eight bound preferentially to IgG1  but  cross-reacted to some extent 
with IgG2a and one was specific for a determinant shared by IgG1, IgG2a, and IgG3. 
The IgA RF derived from unstimulated spleen cells was  primarily directed against 
IgG2a but cross-reacted somewhat with IgG2b. Identical results were obtained with 
two different monoclonal IgG1  and  IgG2a  proteins of the  a  allotype. No allotypic 
specificity was found for the anti-IgG1 RF, which all reacted well with IgG1 of the b 
allotype. In contrast, the IgM anti-IgG2a antibody exhibited such allotypic specificity 
because it failed to react with IgG2a of the b  allotype. When tested on heterologous 
IgG preparations, all anti-IgG1  RF reacted better with rat IgG1, rat IgG2c, bovine 
IgG2, goat IgG2, and rabbit IgG than with mouse IgG1, demonstraing a particular 
homology between these Ig. On the basis of additional cross-reactions with other IgG, 
including rat  IgG2a, rat  IgG2b, bovine IgG1, goat IgG1, human  IgG, and chicken 
IgG, seven different anti-IgG1 clonotypes could be identified. However, despite their 
heterogeneity, nearly all antigenic determinants recognized by anti-IgG 1 RF appeared 
to be located in the hinge region of the molecule. Total lack of binding to IgG1 Fab 
fragments  was  indeed  observed,  and  only  one  antibody  reacted  with  IgG1  Fc 
fragments. Unlike the anti-IgG1 RF, the IgM and the IgA anti-IgG2a antibodies did 
not cross-react with any heterologous IgG of the same panel. 
Altogether, t 1 different RF clonotypes could be distinguished on the basis of their 
fine specificity. The anti-IgG2a specificity of the RF spontaneously produced by 129/ 
Sv mice is thus not due to the absence of other RF specificities in the repertoire of 
these mice. 
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